Molecular Templates, Inc.
MTEMOTCHealthcare
$0.00
$-0.00(-0.00%)
Market Cap$658
P/E Ratio—
52W High$1.59
52W Low$0.000099999997
Molecular Templates, Inc. (MTEM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MTEM · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2024Report Date: Aug 14, 2024EPS Actual
-$1.23
Est. -$1.44 · +14.6%
Revenue
$0.00B
Est. $0.00B · +73.3%
Fiscal Period
Q3 FY2024
FY ends December
Report Date
Aug 14, 2024
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 5-Quarter EPS Beat Streak
MTEM reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2025 | Jun 4, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 29, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Mar 28, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Dec 27, 2024 | -$1.03 | — | — | — | — | — |
| ▲ Q3 FY2024 | Aug 14, 2024 | -$1.44 | -$1.23 | +14.6% | $0.00B | $0.00B | +73.3% |
| ▲ Q2 FY2024 | May 15, 2024 | -$0.78 | $0.08 | +110.3% | $0.01B | $0.01B | +87.9% |
| ▲ Q1 FY2024 | Mar 29, 2024 | -$2.10 | -$0.73 | +65.2% | $0.01B | $0.01B | -9.7% |
| ▲ Q4 FY2023 | Nov 13, 2023 | -$2.70 | -$0.82 | +69.6% | $0.01B | $0.01B | -12.5% |
Q2 FY2025
Jun 4, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 29, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 28, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Dec 27, 2024
EPS Actual
—
EPS Est.
-$1.03
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 14, 2024Beat
EPS Actual
-$1.23
EPS Est.
-$1.44
EPS Surpr.
+14.6%
Revenue
$0.00B
Q2 FY2024
May 15, 2024Beat
EPS Actual
$0.08
EPS Est.
-$0.78
EPS Surpr.
+110.3%
Revenue
$0.01B
Q1 FY2024
Mar 29, 2024Beat
EPS Actual
-$0.73
EPS Est.
-$2.10
EPS Surpr.
+65.2%
Revenue
$0.01B
Q4 FY2023
Nov 13, 2023Beat
EPS Actual
-$0.82
EPS Est.
-$2.70
EPS Surpr.
+69.6%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2024 | $-0.74 | $-0.74 | $-0.74 | 1 |
| Q3 FY2024 | $-1.03 | $-1.03 | $-1.03 | 1 |
| Q2 FY2024 | $-1.44 | $-1.44 | $-1.44 | 1 |
| Q1 FY2024 | $-0.78 | $-0.78 | $-0.78 | 1 |
| Q4 FY2023 | $-0.97 | $-0.97 | $-0.97 | 1 |
| Q3 FY2023 | $-1.95 | $-1.95 | $-1.95 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q3 FY2024 | Aug 14, 2024 | +14.6% | $0.10 | $0.09 | -6.58% |
| ▲ Q2 FY2024 | May 15, 2024 | +110.3% | $0.10 | $0.10 | -2.68% |
| ▲ Q1 FY2024 | Mar 29, 2024 | +65.2% | $0.15 | $0.14 | -7.59% |
| ▲ Q4 FY2023 | Nov 13, 2023 | +69.6% | $0.38 | $0.37 | -0.53% |
| ▲ Q3 FY2023 | Aug 10, 2023 | +37.1% | $0.60 | $0.59 | -1.67% |
| ▼ Q1 FY2023 | Mar 30, 2023 | -56.0% | $0.33 | $0.35 | +6.06% |
| ▲ Q1 FY2023 | Mar 27, 2023 | +40.0% | $0.34 | $0.34 | +0.00% |
| ▲ Q4 FY2022 | Nov 10, 2022 | +8.3% | $0.56 | $0.56 | +0.00% |
Q3 FY2024-6.58%
Report Date
Aug 14, 2024
EPS Beat/Miss
+14.6%
Price Before
$0.10
Price After
$0.09
Q2 FY2024-2.68%
Report Date
May 15, 2024
EPS Beat/Miss
+110.3%
Price Before
$0.10
Price After
$0.10
Q1 FY2024-7.59%
Report Date
Mar 29, 2024
EPS Beat/Miss
+65.2%
Price Before
$0.15
Price After
$0.14
Q4 FY2023-0.53%
Report Date
Nov 13, 2023
EPS Beat/Miss
+69.6%
Price Before
$0.38
Price After
$0.37
Q3 FY2023-1.67%
Report Date
Aug 10, 2023
EPS Beat/Miss
+37.1%
Price Before
$0.60
Price After
$0.59
Q1 FY2023+6.06%
Report Date
Mar 30, 2023
EPS Beat/Miss
-56.0%
Price Before
$0.33
Price After
$0.35
Q1 FY2023+0.00%
Report Date
Mar 27, 2023
EPS Beat/Miss
+40.0%
Price Before
$0.34
Price After
$0.34
Q4 FY2022+0.00%
Report Date
Nov 10, 2022
EPS Beat/Miss
+8.3%
Price Before
$0.56
Price After
$0.56
Avg Beat Reaction-2.72%
Avg Miss Reaction+6.06%
Beat Rate7 / 8 quarters
Largest Move-7.59% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MTEM ends December
Molecular Templates, Inc. (MTEM) most recently reported earnings on August 14, 2024 for Q3 FY2024, posting EPS of $-1.23 — beating the analyst consensus of $-1.44 by +14.6%. MTEM has beaten EPS estimates for 5 consecutive quarters. The next MTEM earnings date is expected around September 1, 2026.
Each quarter, investors track MTEM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MTEM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MTEM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MTEM earnings · 5 questionsMolecular Templates, Inc.'s next earnings report is expected around September 1, 2026. MTEM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MTEM historically reports after market close (AMC).
MTEM earnings datewhen is MTEM earningsMTEM next earnings datewhen does MTEM report earningsMTEM earnings calendar
▸ Source: FMP · Molecular Templates, Inc. SEC filings · US GAAP · Molecular Templates, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026